Skip to main navigation Skip to search Skip to main content

Evaluation of European severe acute respiratory infection (SARI) surveillance, 27 European countries, 2022/23

Diogo F.P. Marques, Dory Kovacs, Miguel Angel Sanchez-Ruiz, Ana Paula Rodrigues, Ausenda Machado, Clara Mazagatos, Susana Monge, Lisa Domegan, Joan O’Donnell, Mariette Hooiveld, Hanne Dorthe Emborg, Baltazar Nunes, Carlos Carvalho, Angela M.C. Rose

Research output: Contribution to journalArticlepeer-review

11 Downloads (Pure)

Abstract

Background: Between 2020 and 2023, ECDC has supported 21 of 30 EU/EEA and six Western Balkan countries by enhancing severe acute respiratory infection (SARI) surveillance to monitor trends, detect unexpected events, evaluate public health interventions, identify risk factors and support vaccine effectiveness studies. Using diverse strategies, countries have implemented SARI surveillance and reported data at national/European levels. Aim: We evaluated European-level SARI surveillance and provided recommendations to achieve objectives and improve key attribute performance. Methods: We analysed 2022/23 surveillance data for completeness. We administered a questionnaire, targeting country-level representatives, to evaluate surveillance attributes (meeting objectives, usefulness, acceptability, timeliness, representativeness) and identify strengths, weaknesses, opportunities and threats. Results: Thirteen countries (13/27) reported data at European level. Data showed good overall completeness but varied across countries and some variables need improvement (vaccination, sequencing). The questionnaire was completed by all 27 countries. Most countries (23/27) reported that the system effectively monitored trends and considered it useful and acceptable (25/27), but only 16 found it timely and 14 representative. Challenges included insufficient case-based data, data linkage issues and insufficient data completeness. Slow/inefficient manual data extraction affected timeliness, while insufficient geographical coverage affected representativeness. Multi-pathogen surveillance was identified as the main strength, heterogeneity of systems the main weakness, improvements of hospital information systems the main opportunity, and lack of sustainable funding the main threat. Conclusions: SARI surveillance was perceived as effective in monitoring trends, useful and acceptable. To achieve additional objectives and enhance timeliness and representativeness, we recommend improving data completeness, digitalisation/automation and geographical coverage.

Original languageEnglish
Article number2400655
JournalEurosurveillance
Volume30
Issue number20
DOIs
Publication statusPublished - 22 May 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Evaluation of European severe acute respiratory infection (SARI) surveillance, 27 European countries, 2022/23'. Together they form a unique fingerprint.

Cite this